Organizers

After graduating with his Ph.D. in Biochemistry and Molecular Biology from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Zhaodong did his postdoctoral research at Dana-Farber Cancer Institute and UMass Medical School. He is enthusiastic about science communication and both basic and translational sciences that would lead to new effective therapies for human diseases. Zhaodong was a scientific editor at eBioMedicine, The Lancet, before he joined Cancer Cell in 2022.

« Go Back